Guerbet SA (EPA:GBT)
France · Delayed Price · Currency is EUR 8.84
-0.43 (-4.64%)
At close: Mar 13, 2026
Guerbet Market Cap
Guerbet has a market cap or net worth of €111.39 million as of March 13, 2026. Its market cap has decreased by -65.96% in one year.
Market Cap
111.39M
Enterprise Value
104.39M
Revenue
799.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
€8.84
Market Cap Chart
Since March 3, 1992, Guerbet's market cap has decreased from 142.85M to 111.39M, a decrease of -22.02%. That is a compound annual growth rate of -0.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 111.39M | -38.18% |
| Dec 31, 2025 | 180.20M | -46.68% |
| Dec 31, 2024 | 337.92M | 37.29% |
| Dec 29, 2023 | 246.14M | 14.95% |
| Dec 30, 2022 | 214.13M | -54.42% |
| Dec 31, 2021 | 469.83M | 13.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 226.54M |
| Carvolix | 191.95M |
| Median Technologies | 183.67M |
| Diagnostic Medical Systems | 33.15M |
| Implanet | 27.88M |
| Novacyt | 27.08M |
| Ikonisys | 23.45M |
| Theraclion | 21.14M |